Great presentation.
There is always a slight upgrade to each presentation.
My suggestion to the company is after Phase 1 trial results is to raise $40 mil at $2 a share and lets go straight into Phase 2 for :
Stroke - which is a given and also :
HIE
TBI and concussion
Surgically induced stroke
and Alzheimers
A multi pronged Phase 2 for a huge unmet need
Ann: AGM Presentation, page-2
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.06M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 74.3¢ | $107.9K | 143.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6522 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 11047 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |